サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1405828

アレルギー診断・治療薬の市場規模、シェア、動向分析レポート：タイプ別、アレルゲンタイプ別、検査タイプ別、地域別、セグメント予測、2024年～2030年

Allergy Diagnostics And Therapeutics Market Size, Share & Trends Analysis Report By Type (Diagnostics, Therapeutics), By Allergen Type (Food, Inhaled, Drug), By Test Type, By Region, And Segment Forecasts, 2024 - 2030
出版日: | 発行: Grand View Research | ページ情報: 英文 150 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.90円
アレルギー診断・治療薬の市場規模、シェア、動向分析レポート：タイプ別、アレルゲンタイプ別、検査タイプ別、地域別、セグメント予測、2024年～2030年
出版日: 2023年12月11日
発行: Grand View Research
ページ情報: 英文 150 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

アレルギー診断・治療薬市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界のアレルギー診断・治療薬の市場規模は、2023年に583億1,000万米ドルと推計され、2024年から2030年にかけてCAGR8.7％で成長すると予測されています。

アレルギー疾患の罹患率の増加は、先進的な治療薬への需要と相まって、今後数年間の市場成長を促進すると予測されています。米国アレルギー喘息免疫学会（AAAAI）が発表した推計によると、アレルギー性鼻炎は世界人口の約10％から30％が罹患しており、世界的にアレルギー治療薬の採用に影響を与えています。

治療成績の向上や疾病管理のための人工知能技術の使用など、技術的に高度な製品の統合が進んでいることは、開業医の意思決定プロセスに役立っています。さらに、鼻炎などのアレルギーを診断するためのmヘルスアプリの採用が増加していることも、市場を押し上げると予想されます。例えば、MASK-Airアプリはアレルギー性鼻炎に特化しています。

モノクローナル抗体は、その高い有効性、長期にわたる忍容性、安全性により、特定のアレルギーの懸念を払拭する新しい治療法の開発に貢献すると予想されます。そのため、主な企業は、特にモノクローナル抗体のような、選択的なターゲットに向けたターゲット特異的なメカニズムで設計された、新規かつ効果的な生物学的製剤を開発しています。さらに、アレルギー疾患に対する非常に重要なモノクローナル抗体の一貫した製品承認は、成長範囲を拡大すると予想されます。

抗免疫グロブリンE（IgE）抗体、サイトカインモジュレーター、DNAワクチン接種などの新しい治療法がアレルギー疾患の治療に用いられています。オマリズマブは組換えヒト化IgG1モノクローナル抗IgE抗体で、アレルギー性の慢性蕁麻疹や喘息の治療に使用されます。2021年4月、Genentech（Roche Group）は、自己注射用プレフィルドシリンジが、慢性特発性蕁麻疹アレルギー性喘息、鼻ポリープを適応症とするゾレア（オマリズマブ）の米国におけるFDA承認を取得したと発表しました。

アレルギー診断・治療薬市場は、Merck &Co., Inc.、Thermo Fisher Scientific, Inc.、Abbott、Pfizer, Inc.などの注目すべき企業が強い存在感を示しており、競争は中程度です。これらの企業は、能力を高め、製品ポートフォリオを拡大し、能力を向上させるために様々な取り組みを行っています。

アレルギー診断・治療薬市場レポートハイライト

  • 消耗品製品セグメントは、2022年のアレルギー診断・治療薬市場で最大のシェアを占めました。感度、精度、検出速度の向上につながるMeDALLアレルゲンチップを含む製品の登場が市場成長を促進すると予測されます。
  • 薬物アレルギー分野は、治療選択肢の増加や患者の薬物アレルギーに対する意識の高まりにより、高成長が見込まれています。
  • 喘息、鼻炎、アレルギー性結膜炎などのアレルギーの発生率の増加、世界のアレルギー検査需要の増加により、2022年には試験管内検査が最も高いシェアを占めました。
  • 2022年の薬剤クラス別ではエピネフリンが優位を占めました。主要企業による費用対効果の高いエピネフリン自己注射器のイントロダクションは、市場の成長を大幅に増大させると予想されます。
  • 2022年のアレルギー診断・治療薬市場は、アレルギー治療薬に関連する高い可能性に対する理解の高まりにより、北米が支配的でした。このため、米国を拠点とする企業は、これらの医薬品の開発に多額の投資を行うようになっています。
  • アジア太平洋地域は、特に喘息、慢性咳嗽、食物アレルギーの罹患率が上昇しているため、今後かなりの成長が見込まれます。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 市場変数、動向、および範囲

  • 市場の系統
  • アレルギー診断・治療薬市場-市場力学
  • ビジネス環境ツール分析：アレルギー診断・治療薬市場
  • パイプライン分析

第4章 アレルギー診断・治療薬市場：タイプの推定・動向分析

  • アレルギー診断・治療薬市場、タイプ別：重要なポイント
  • アレルギー診断・治療薬市場：タイプの動向と市場シェア分析、2023年・2030年
  • 診断
  • 治療薬

第5章 アレルギー診断・治療薬市場：アレルゲンタイプの推定・動向分析

  • アレルギー診断・治療薬市場、アレルゲンタイプ別：重要なポイント
  • アレルギー診断・治療薬市場：アレルゲンタイプの動向と市場シェア分析、2023年・2030年
  • 食品
  • 吸入
  • 医薬品
  • その他のアレルゲンタイプ

第6章 アレルギー診断市場：検査タイプの推定・動向分析

  • アレルギー診断市場、検査タイプ別：重要なポイント
  • アレルギー診断市場：検査タイプの動向と市場シェア分析、2023年・2030年
  • In Vivo試験
  • In Vitro試験

第7章 アレルギー診断・治療薬市場：地域推定・動向分析

  • アレルギー診断・治療薬市場：地域変動分析、2023年・2030年
  • 北米
    • 北米のアレルギー診断・治療薬市場推計・予測、2018年～2030年
    • 米国
    • カナダ
  • 欧州
    • 欧州のアレルギー診断・治療薬市場推計・予測、2018年～2030年
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • デンマーク
    • スウェーデン
    • ノルウェー
  • アジア太平洋
    • アジア太平洋のアレルギー診断・治療薬市場推計・予測、2018年～2030年
    • 日本
    • 中国
    • インド
    • オーストラリア
    • タイ
    • 韓国
  • ラテンアメリカ
    • ラテンアメリカのアレルギー診断・治療薬市場推計・予測、2018年～2030年
    • ブラジル
    • メキシコ
    • アルゼンチン
  • 中東・アフリカ
    • 中東・アフリカのアレルギー診断・治療薬市場推計・予測、2018年～2030年
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第8章 競合情勢

  • 企業の分類
  • 企業の市場シェア分析、2023年
  • 戦略マッピング
  • 企業プロファイル・一覧表
    • R-Biopharm AG
    • EUROIMMUN Medizinische Labordiagnostika AG
    • DASIT Group SPA
    • AESKU.GROUP GmbH
    • bioMerieux
    • Danaher
    • Thermo Fisher Scientific, Inc
    • Stallergenes Greer
    • Minaris Medical America, Inc.
    • Siemens Healthcare GmbH
    • Omega Diagnostics Group PLC
    • HYCOR Biomedical
    • Lincoln Diagnostics, Inc.
    • Alcon
    • HOB Biotech Group Corp., Ltd.
    • AbbVie Inc.
    • Allergy Therapeutics
    • Sanofi
    • Pfizer Inc.
    • Teva Pharmaceutical Industries Ltd.
    • Sun Pharmaceutical Industries Ltd.
    • GSK plc
    • F. Hoffmann-La Roche Ltd.
    • Merck &Co., Inc.
    • Astellas Pharma Inc.
図表

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviation
  • Table 3 Global Allergy Diagnostics & Therapeutics Market, By Region, 2018 - 2030 (USD Million)
  • Table 4 Global Allergy Diagnostics & Therapeutics Market, By Type, 2018 - 2030 (USD Million)
  • Table 5 Global Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018 - 2030 (USD Million)
  • Table 6 Global Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018 - 2030 (USD Million)
  • Table 7 Global Allergy Diagnostics & Therapeutics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 8 North America Allergy Diagnostics & Therapeutics Market, By Country, 2018 - 2030 (USD Million)
  • Table 9 North America Allergy Diagnostics & Therapeutics Market, By Type, 2018 - 2030 (USD Million)
  • Table 10 North America Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018 - 2030 (USD Million)
  • Table 11 North America Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018 - 2030 (USD Million)
  • Table 12 North America Allergy Diagnostics & Therapeutics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 13 U.S. Allergy Diagnostics & Therapeutics Market, By Type, 2018 - 2030 (USD Million)
  • Table 14 U.S. Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018 - 2030 (USD Million)
  • Table 15 U.S. Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018 - 2030 (USD Million)
  • Table 16 U.S. Allergy Diagnostics & Therapeutics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 17 Canada Allergy Diagnostics & Therapeutics Market, By Type, 2018 - 2030 (USD Million)
  • Table 18 Canada Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018 - 2030 (USD Million)
  • Table 19 Canada Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018 - 2030 (USD Million)
  • Table 20 Canada Allergy Diagnostics & Therapeutics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 21 Europe Allergy Diagnostics & Therapeutics Market, By Country, 2018 - 2030 (USD Million)
  • Table 22 Europe Allergy Diagnostics & Therapeutics Market, By Type, 2018 - 2030 (USD Million)
  • Table 23 Europe Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018 - 2030 (USD Million)
  • Table 24 Europe Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018 - 2030 (USD Million)
  • Table 25 Europe Allergy Diagnostics & Therapeutics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 26 UK Allergy Diagnostics & Therapeutics Market, By Type, 2018 - 2030 (USD Million)
  • Table 27 UK Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018 - 2030 (USD Million)
  • Table 28 UK Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018 - 2030 (USD Million)
  • Table 29 UK Allergy Diagnostics & Therapeutics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 30 Germany Allergy Diagnostics & Therapeutics Market, By Type, 2018 - 2030 (USD Million)
  • Table 31 Germany Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018 - 2030 (USD Million)
  • Table 32 Germany Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018 - 2030 (USD Million)
  • Table 33 Germany Allergy Diagnostics & Therapeutics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 34 France Allergy Diagnostics & Therapeutics Market, By Type, 2018 - 2030 (USD Million)
  • Table 35 France Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018 - 2030 (USD Million)
  • Table 36 France Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018 - 2030 (USD Million)
  • Table 37 France Allergy Diagnostics & Therapeutics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 38 Italy Allergy Diagnostics & Therapeutics Market, By Type, 2018 - 2030 (USD Million)
  • Table 39 Italy Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018 - 2030 (USD Million)
  • Table 40 Italy Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018 - 2030 (USD Million)
  • Table 41 Italy Allergy Diagnostics & Therapeutics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 42 Spain Allergy Diagnostics & Therapeutics Market, By Type, 2018 - 2030 (USD Million)
  • Table 43 Spain Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018 - 2030 (USD Million)
  • Table 44 Spain Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018 - 2030 (USD Million)
  • Table 45 Spain Allergy Diagnostics & Therapeutics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 46 Denmark Allergy Diagnostics & Therapeutics Market, By Type, 2018 - 2030 (USD Million)
  • Table 47 Denmark Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018 - 2030 (USD Million)
  • Table 48 Denmark Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018 - 2030 (USD Million)
  • Table 49 Denmark Allergy Diagnostics & Therapeutics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 50 Sweden Allergy Diagnostics & Therapeutics Market, By Type, 2018 - 2030 (USD Million)
  • Table 51 Sweden Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018 - 2030 (USD Million)
  • Table 52 Sweden Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018 - 2030 (USD Million)
  • Table 53 Sweden Allergy Diagnostics & Therapeutics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 54 Norway Allergy Diagnostics & Therapeutics Market, By Type, 2018 - 2030 (USD Million)
  • Table 55 Norway Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018 - 2030 (USD Million)
  • Table 56 Norway Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018 - 2030 (USD Million)
  • Table 57 Norway Allergy Diagnostics & Therapeutics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 58 Asia Pacific Allergy Diagnostics & Therapeutics Market, By Country, 2018 - 2030 (USD Million)
  • Table 59 Asia Pacific Allergy Diagnostics & Therapeutics Market, By Type, 2018 - 2030 (USD Million)
  • Table 60 Asia Pacific Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018 - 2030 (USD Million)
  • Table 61 Asia Pacific Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018 - 2030 (USD Million)
  • Table 62 Asia Pacific Allergy Diagnostics & Therapeutics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 63 Japan Allergy Diagnostics & Therapeutics Market, By Type, 2018 - 2030 (USD Million)
  • Table 64 Japan Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018 - 2030 (USD Million)
  • Table 65 Japan Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018 - 2030 (USD Million)
  • Table 66 Japan Allergy Diagnostics & Therapeutics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 67 China Allergy Diagnostics & Therapeutics Market, By Type, 2018 - 2030 (USD Million)
  • Table 68 China Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018 - 2030 (USD Million)
  • Table 69 China Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018 - 2030 (USD Million)
  • Table 70 China Allergy Diagnostics & Therapeutics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 71 India Allergy Diagnostics & Therapeutics Market, By Type, 2018 - 2030 (USD Million)
  • Table 72 India Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018 - 2030 (USD Million)
  • Table 73 India Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018 - 2030 (USD Million)
  • Table 74 India Allergy Diagnostics & Therapeutics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 75 Australia Allergy Diagnostics & Therapeutics Market, By Type, 2018 - 2030 (USD Million)
  • Table 76 Australia Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018 - 2030 (USD Million)
  • Table 77 Australia Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018 - 2030 (USD Million)
  • Table 78 Australia Allergy Diagnostics & Therapeutics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 79 South Korea Allergy Diagnostics & Therapeutics Market, By Type, 2018 - 2030 (USD Million)
  • Table 80 South Korea Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018 - 2030 (USD Million)
  • Table 81 South Korea Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018 - 2030 (USD Million)
  • Table 82 South Korea Allergy Diagnostics & Therapeutics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 83 Thailand Allergy Diagnostics & Therapeutics Market, By Type, 2018 - 2030 (USD Million)
  • Table 84 Thailand Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018 - 2030 (USD Million)
  • Table 85 Thailand Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018 - 2030 (USD Million)
  • Table 86 Thailand Allergy Diagnostics & Therapeutics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 87 Latin America Allergy Diagnostics & Therapeutics Market, By Country, 2018 - 2030 (USD Million)
  • Table 88 Latin America Allergy Diagnostics & Therapeutics Market, By Type, 2018 - 2030 (USD Million)
  • Table 89 Latin America Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018 - 2030 (USD Million)
  • Table 90 Latin America Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018 - 2030 (USD Million)
  • Table 91 Latin America Allergy Diagnostics & Therapeutics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 92 Brazil Allergy Diagnostics & Therapeutics Market, By Type, 2018 - 2030 (USD Million)
  • Table 93 Brazil Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018 - 2030 (USD Million)
  • Table 94 Brazil Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018 - 2030 (USD Million)
  • Table 95 Brazil Allergy Diagnostics & Therapeutics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 96 Mexico Allergy Diagnostics & Therapeutics Market, By Type, 2018 - 2030 (USD Million)
  • Table 97 Mexico Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018 - 2030 (USD Million)
  • Table 98 Mexico Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018 - 2030 (USD Million)
  • Table 99 Mexico Allergy Diagnostics & Therapeutics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 100 Argentina Allergy Diagnostics & Therapeutics Market, By Type, 2018 - 2030 (USD Million)
  • Table 101 Argentina Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018 - 2030 (USD Million)
  • Table 102 Argentina Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018 - 2030 (USD Million)
  • Table 103 Argentina Allergy Diagnostics & Therapeutics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 104 MEA Allergy Diagnostics & Therapeutics Market, By Country, 2018 - 2030 (USD Million)
  • Table 105 MEA Allergy Diagnostics & Therapeutics Market, By Type, 2018 - 2030 (USD Million)
  • Table 106 MEA Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018 - 2030 (USD Million)
  • Table 107 MEA Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018 - 2030 (USD Million)
  • Table 108 MEA Allergy Diagnostics & Therapeutics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 109 South Africa Allergy Diagnostics & Therapeutics Market, By Type, 2018 - 2030 (USD Million)
  • Table 110 South Africa Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018 - 2030 (USD Million)
  • Table 111 South Africa Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018 - 2030 (USD Million)
  • Table 112 South Africa Allergy Diagnostics & Therapeutics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 113 Saudi Arabia Allergy Diagnostics & Therapeutics Market, By Type, 2018 - 2030 (USD Million)
  • Table 114 Saudi Arabia Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018 - 2030 (USD Million)
  • Table 115 Saudi Arabia Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018 - 2030 (USD Million)
  • Table 116 Saudi Arabia Allergy Diagnostics & Therapeutics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 117 UAE Allergy Diagnostics & Therapeutics Market, By Type, 2018 - 2030 (USD Million)
  • Table 118 UAE Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018 - 2030 (USD Million)
  • Table 119 UAE Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018 - 2030 (USD Million)
  • Table 120 UAE Allergy Diagnostics & Therapeutics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 121 Kuwait Allergy Diagnostics & Therapeutics Market, By Type, 2018 - 2030 (USD Million)
  • Table 122 Kuwait Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018 - 2030 (USD Million)
  • Table 123 Kuwait Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018 - 2030 (USD Million)
  • Table 124 Kuwait Allergy Diagnostics & Therapeutics Market, By Test Type, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Allergy Diagnostics & Therapeutics Market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modelling for market share assessment.
  • Fig. 8 Market formulation & validation
  • Fig. 9 Allergy Diagnostics & Therapeutics Market snapshot
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook.
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Allergy Diagnostics & Therapeutics Market driver impact
  • Fig. 14 Allergy Diagnostics & Therapeutics Market restraint impact
  • Fig. 15 SWOT analysis, by factor (political & legal, economic, and technological)
  • Fig. 16 Industry Analysis - Porter's
  • Fig. 17 Strategy mapping
  • Fig. 18 Allergy Diagnostics & Therapeutics Market: Type outlook and key takeaways
  • Fig. 19 Allergy Diagnostics & Therapeutics Market: Type movement analysis & market share 2023 & 2030
  • Fig. 20 Diagnostics Market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 21 Therapeutics Market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Instruments market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Consumable market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 Services market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25 Antihistamines Allergy Diagnostics & Therapeutics Market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Angiotensin 2 Receptor Blockers Allergy Diagnostics & Therapeutics Market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 Decongestants Allergy Diagnostics & Therapeutics Market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 Corticosteroids Allergy Diagnostics & Therapeutics Market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 29 Mast Cell Stabilizers Allergy Diagnostics & Therapeutics Market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 30 Leukotriene Inhibitors Allergy Diagnostics & Therapeutics Market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 Nasal Anti-cholinergic Allergy Diagnostics & Therapeutics Market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 32 Immuno-modulators Allergy Diagnostics & Therapeutics Market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 33 Epinephrine Allergy Diagnostics & Therapeutics Market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 34 Immunotherapy Allergy Diagnostics & Therapeutics Market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 35 Allergy Diagnostics & Therapeutics Market: Allergen Type outlook and key takeaways
  • Fig. 36 Allergy Diagnostics & Therapeutics Market: Allergen Type movement analysis & market share 2023 & 2030
  • Fig. 37 Food market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 38 Dairy Products market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 39 Poultry Product market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 40 Tree Nuts market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 41 Peanuts market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 42 Shellfish market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 43 Wheat market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 44 Soy market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 45 Other Food Allergens market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 46 Inhaled market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 47 Drug market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 48 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 49 Allergy Diagnostics & Therapeutics Market: Test Type outlook and key takeaways
  • Fig. 50 Allergy Diagnostics & Therapeutics Market: Test Type movement analysis & market share 2023 & 2030
  • Fig. 51 In vivo Test market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 52 Skin Prick Test market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 53 Intradermal Test market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 54 Patch Test market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 55 In Vitro Test market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 56 Allergy Diagnostics & Therapeutics Market: Regional outlook and key takeaways
  • Fig. 57 Regional outlook, 2023 & 2030
  • Fig. 58 North America
  • Fig. 59 North America market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 60 U.S. key country dynamics
  • Fig. 61 U.S. market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 62 Canada key country dynamics
  • Fig. 63 Canada market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 64 Europe
  • Fig. 65 Europe market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 66 UK key country dynamics
  • Fig. 67 UK market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 68 Germany
  • Fig. 69 Germany market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 70 France key country dynamics
  • Fig. 71 France market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 72 Italy key country dynamics
  • Fig. 73 Italy market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 74 Spain key country dynamics
  • Fig. 75 Spain market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 76 Denmark key country dynamics
  • Fig. 77 Denmark market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 78 Sweden key country dynamics
  • Fig. 79 Sweden market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 80 Norway key country dynamics
  • Fig. 81 Norway market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 82 Asia-Pacific
  • Fig. 83 Asia-Pacific market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 84 Japan key country dynamics
  • Fig. 85 Japan market estimates and forecast, 2018 - 2030(USD Million)
  • Fig. 86 China key country dynamics
  • Fig. 87 China market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 88 India key country dynamics
  • Fig. 89 India market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 90 South Korea key country dynamics
  • Fig. 91 South Korea market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 92 Australia key country dynamics
  • Fig. 93 Australia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 94 Thailand key country dynamics
  • Fig. 95 Thailand market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 96 Latin America
  • Fig. 97 Latin America market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 98 Brazil key country dynamics
  • Fig. 99 Brazil market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 100 Mexico key country dynamics
  • Fig. 101 Mexico market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 102 Argentina key country dynamics
  • Fig. 103 Argentina market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 104 Middle East & Africa
  • Fig. 105 MEA market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 106 South Africa key country dynamics
  • Fig. 107 South Africa market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 108 Saudi Arabia key country dynamics
  • Fig. 109 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 110 UAE key country dynamics
  • Fig. 111 UAE market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 112 Kuwait key country dynamics
  • Fig. 113 Kuwait market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 114 Market differentiators
  • Fig. 115 Key company market share analysis, 2023
目次
Product Code: 978-1-68038-701-8

Allergy Diagnostics And Therapuetics Market Growth & Trends:

The global allergy diagnostics and therapeutics market size was estimated at USD 58.31 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 8.7% from 2024 to 2030, according to a new report by Grand View Research, Inc. Increasing incidences of allergic diseases, coupled with demand for advanced therapeutics, is expected to drive the market growth in the coming years. According to estimates published by the American Academy of Allergy Asthma & Immunology (AAAAI), allergic rhinitis affects approximately 10-30% of the global population, thereby impacting the adoption of allergy therapeutics globally.

The increasing integration of technologically advanced products, such as the use of artificial intelligence technology to advance treatment outcomes and manage diseases, helps practitioners in the decision-making process. Furthermore, the rising adoption of mHealth apps for diagnosing allergies such as rhinitis is expected to boost the market. For instance, the MASK-Air app is dedicated specifically to allergic rhinitis.

Monoclonal antibodies are anticipated to contribute to the development of new therapies that eradicate specific allergy concerns, owing to their higher efficacy, long-term tolerability, and safety. Hence, key companies are developing novel & effective biologic-based therapies designed with target-specific mechanisms directed toward selective targets, especially monoclonal antibodies. In addition, consistent product approvals of highly significant monoclonal antibodies for allergy disorders are anticipated to expand the scope for growth.

New therapies such as anti-immunoglobulin E (IgE) antibodies, cytokine modulators, and DNA vaccinations are being used to treat allergic disorders. Omalizumab is a recombinant humanized IgG1 monoclonal anti-IgE antibody, which is used for treating allergic chronic urticaria and asthma. In April 2021, Genentech (Roche Group) announced that its prefilled syringe for self-injection has received FDA approval for Xolair (omalizumab) in the U.S. for chronic idiopathic urticaria allergic asthma, and nasal polyps.

The allergy diagnostics & therapeutics market is moderately competitive, with a strong presence of notable companies such as Merck & Co., Inc, Thermo Fisher Scientific, Inc., Abbott, and Pfizer, Inc. These players are undertaking various initiatives to increase their capabilities, expand their product portfolios, and improve their competencies.

Allergy Diagnostics And Therapuetics Market Report Highlights:

  • The consumables product segment held the largest share in the allergy diagnostics & therapeutics market in 2022. The advent of products that include the MeDALL allergen-chip, which is linked with increased sensitivity, precision, and faster detection, is anticipated to encourage market growth
  • The drug allergies segment is expected to advance lucratively due to the increasing availability of treatment options and growing awareness about drug allergies among patients
  • In vitro tests accounted for the highest share in 2022 due to an increase in the incidence of allergies such as asthma, rhinitis, & allergic conjunctivitis, and a rise in demand for allergy testing globally
  • Epinephrine dominated the drug class segment in 2022. The introduction of cost-effective epinephrine autoinjectors by key companies is expected to significantly augment market growth
  • North America dominated the allergy diagnostics & therapeutics market in 2022, due to an increase in understanding of the high potential associated with allergy drugs. This has driven U.S.-based firms to make considerable investments in the development of these drugs
  • Asia Pacific is expected to witness considerable growth in the future owing to the rising incidences of asthma, chronic cough, and food allergies, among others, in the region

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
  • 1.3. Information Procurement
    • 1.3.1. Purchased Database
    • 1.3.2. GVR's Internal Database
    • 1.3.3. Secondary Sources & Third-Party Perspectives
    • 1.3.4. Primary Research
    • 1.3.5. Details of Primary Research
  • 1.4. Information Analysis
    • 1.4.1. Data Analysis Models
  • 1.5. Market Formulation & Data Visualization
    • 1.5.1. Commodity Flow Analysis
      • 1.5.1.1. Approach 1: Commodity flow approach
      • 1.5.1.2. Approach 2: Country-wise market estimation using bottom-up approach
  • 1.6. Data Validation & Publishing
  • 1.7. Global Market: CAGR Calculation
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segmental Snapshot
  • 2.3. Competitive Insights Snapshot

Chapter 3. Market Variables, Trends, and Scope

  • 3.1. Market Lineage
    • 3.1.1. Parent Market Analysis
    • 3.1.2. Ancillary Market Analysis
  • 3.2. Allergy Diagnostics & Therapeutics Market - Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Rising incidence of allergies
      • 3.2.1.2. Advancements in technology and launch of new products
      • 3.2.1.3. High adoption of immunotherapy drugs
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Low adoption and penetration in developing countries due to the high cost of technology
      • 3.2.2.2. Lack of allergen standardization
  • 3.3. Business Environmental Tools Analysis: Allergy Diagnostics & Therapeutics Market
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTLE Analysis
  • 3.4. Pipeline Analysis

Chapter 4. Allergy Diagnostics & Therapeutics Market: Type Estimates & Trend Analysis

  • 4.1. Allergy Diagnostics & Therapeutics Market, By Type: Key Takeaways
  • 4.2. Allergy Diagnostics & Therapeutics Market: Type Movement & Market Share Analysis, 2023 & 2030
  • 4.3. Diagnostics
    • 4.3.1. Global Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 4.3.2. Instruments
      • 4.3.2.1. Global Instruments Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 4.3.3. Consumables
      • 4.3.3.1. Global Consumables Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 4.3.4. Services
      • 4.3.4.1. Global Services Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Therapeutics
    • 4.4.1. Global Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 4.4.2. Antihistamines
      • 4.4.2.1. Global Antihistamines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 4.4.3. Decongestants
      • 4.4.3.1. Global Decongestants Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 4.4.4. Corticosteroids
      • 4.4.4.1. Global Corticosteroids Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 4.4.5. Mast Cell Stabilizers
      • 4.4.5.1. Global Mast Cell Stabilizers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 4.4.6. Leukotriene Inhibitors
      • 4.4.6.1. Global Leukotriene Inhibitors Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 4.4.7. Nasal Anti-cholinergic
      • 4.4.7.1. Global Nasal Anti-cholinergic Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 4.4.8. Immuno-modulators
      • 4.4.8.1. Global Immuno-modulators Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 4.4.9. Epinephrine
      • 4.4.9.1. Global Epinephrine Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 4.4.10. Immunotherapy
      • 4.4.10.1. Global Immunotherapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Allergy Diagnostics & Therapeutics Market: Allergen Type Estimates & Trend Analysis

  • 5.1. Allergy Diagnostics & Therapeutics Market, By Allergen type: Key Takeaways
  • 5.2. Allergy Diagnostics & Therapeutics Market: Allergen type Movement & Market Share Analysis, 2023 & 2030
  • 5.3. Food
    • 5.3.1. Global Food Allergy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 5.3.2. Dairy Products
      • 5.3.2.1. Global Dairy Products Allergy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 5.3.3. Poultry Product
      • 5.3.3.1. Global Poultry Products Allergy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 5.3.4. Tree Nuts
      • 5.3.4.1. Global Tree Nuts Allergy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 5.3.5. Peanuts
      • 5.3.5.1. Global Peanut Allergy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 5.3.6. Shellfish
      • 5.3.6.1. Global Shellfish Allergy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 5.3.7. Wheat
      • 5.3.7.1. Global Wheat Allergy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 5.3.8. Soy
      • 5.3.8.1. Global Soy Allergy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 5.3.9. Other Food Allergens
      • 5.3.9.1. Global Food Allergens Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Inhaled
    • 5.4.1. Global Inhaled Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Drug
    • 5.5.1. Global Drug Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Others allergen types
    • 5.6.1. Global Other allergen types Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Allergy Diagnostics Market: Test Type Estimates & Trend Analysis

  • 6.1. Allergy Diagnostics Market, By Test Type: Key Takeaways
  • 6.2. Allergy Diagnostics Market: Test Type Movement & Market Share Analysis, 2023 & 2030
  • 6.3. In Vivo tests
    • 6.3.1. Global In Vivo tests Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.3.2. Skin Prick Test
      • 6.3.2.1. Global Skin Prick Test Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.3.3. Intradermal Test
      • 6.3.3.1. Global Intradermal Test Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.3.4. Patch Test
      • 6.3.4.1. Global Patch Test Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.4. In Vitro tests
    • 6.4.1. Global In Vitro tests Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Allergy Diagnostics & Therapeutics Market: Regional Estimates & Trend Analysis

  • 7.1. Allergy Diagnostics & Therapeutics Market: Regional Movement Analysis, 2023 & 2030
  • 7.2. North America
    • 7.2.1. North America Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.2.2. U.S.
      • 7.2.2.1. Key Country Dynamics
      • 7.2.2.2. Competitive Scenario
      • 7.2.2.3. Prevalence Insights
      • 7.2.2.4. Regulatory Framework
      • 7.2.2.5. Reimbursement Structure
      • 7.2.2.6. U.S. Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.2.3. Canada
      • 7.2.3.1. Key Country Dynamics
      • 7.2.3.2. Competitive Scenario
      • 7.2.3.3. Prevalence Insights
      • 7.2.3.4. Regulatory Framework
      • 7.2.3.5. Reimbursement Structure
      • 7.2.3.6. Canada Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.3. Europe
    • 7.3.1. Europe Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.3.2. UK
      • 7.3.2.1. Key Country Dynamics
      • 7.3.2.2. Competitive Scenario
      • 7.3.2.3. Prevalence Insights
      • 7.3.2.4. Regulatory Framework
      • 7.3.2.5. Reimbursement Structure
      • 7.3.2.6. UK Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.3.3. Germany
      • 7.3.3.1. Key Country Dynamics
      • 7.3.3.2. Competitive Scenario
      • 7.3.3.3. Prevalence Insights
      • 7.3.3.4. Regulatory Framework
      • 7.3.3.5. Reimbursement Structure
      • 7.3.3.6. Germany Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.3.4. France
      • 7.3.4.1. Key Country Dynamics
      • 7.3.4.2. Competitive Scenario
      • 7.3.4.3. Prevalence Insights
      • 7.3.4.4. Regulatory Framework
      • 7.3.4.5. Reimbursement Structure
      • 7.3.4.6. France Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.3.5. Italy
      • 7.3.5.1. Key Country Dynamics
      • 7.3.5.2. Competitive Scenario
      • 7.3.5.3. Prevalence Insights
      • 7.3.5.4. Regulatory Framework
      • 7.3.5.5. Reimbursement Structure
      • 7.3.5.6. Italy Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.3.6. Spain
      • 7.3.6.1. Key Country Dynamics
      • 7.3.6.2. Competitive Scenario
      • 7.3.6.3. Prevalence Insights
      • 7.3.6.4. Regulatory Framework
      • 7.3.6.5. Reimbursement Structure
      • 7.3.6.6. Spain Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.3.7. Denmark
      • 7.3.7.1. Key Country Dynamics
      • 7.3.7.2. Competitive Scenario
      • 7.3.7.3. Prevalence Insights
      • 7.3.7.4. Regulatory Framework
      • 7.3.7.5. Reimbursement Structure
      • 7.3.7.6. Denmark Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.3.8. Sweden
      • 7.3.8.1. Key Country Dynamics
      • 7.3.8.2. Competitive Scenario
      • 7.3.8.3. Prevalence Insights
      • 7.3.8.4. Regulatory Framework
      • 7.3.8.5. Reimbursement Structure
      • 7.3.8.6. Sweden Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.3.9. Norway
      • 7.3.9.1. Key Country Dynamics
      • 7.3.9.2. Competitive Scenario
      • 7.3.9.3. Prevalence Insights
      • 7.3.9.4. Regulatory Framework
      • 7.3.9.5. Reimbursement Structure
      • 7.3.9.6. Norway Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. Asia Pacific Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.4.2. Japan
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Competitive Scenario
      • 7.4.2.3. Prevalence Insights
      • 7.4.2.4. Regulatory Framework
      • 7.4.2.5. Reimbursement Structure
      • 7.4.2.6. Japan Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.4.3. China
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Competitive Scenario
      • 7.4.3.3. Prevalence Insights
      • 7.4.3.4. Regulatory Framework
      • 7.4.3.5. Reimbursement Structure
      • 7.4.3.6. China Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.4.4. India
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Competitive Scenario
      • 7.4.4.3. Prevalence Insights
      • 7.4.4.4. Regulatory Framework
      • 7.4.4.5. Reimbursement Structure
      • 7.4.4.6. India Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.4.5. Australia
      • 7.4.5.1. Key Country Dynamics
      • 7.4.5.2. Competitive Scenario
      • 7.4.5.3. Prevalence Insights
      • 7.4.5.4. Regulatory Framework
      • 7.4.5.5. Reimbursement Structure
      • 7.4.5.6. Australia Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.4.6. Thailand
      • 7.4.6.1. Key Country Dynamics
      • 7.4.6.2. Competitive Scenario
      • 7.4.6.3. Prevalence Insights
      • 7.4.6.4. Regulatory Framework
      • 7.4.6.5. Reimbursement Structure
      • 7.4.6.6. Thailand Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.4.7. South Korea
      • 7.4.7.1. Key Country Dynamics
      • 7.4.7.2. Competitive Scenario
      • 7.4.7.3. Prevalence Insights
      • 7.4.7.4. Regulatory Framework
      • 7.4.7.5. Reimbursement Structure
      • 7.4.7.6. South Korea Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Latin America
    • 7.5.1. Latin America Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.2. Brazil
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. Prevalence Insights
      • 7.5.2.4. Regulatory Framework
      • 7.5.2.5. Reimbursement Structure
      • 7.5.2.6. Brazil Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. Mexico
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Prevalence Insights
      • 7.5.3.4. Regulatory Framework
      • 7.5.3.5. Reimbursement Structure
      • 7.5.3.6. Mexico Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.4. Argentina
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Competitive Scenario
      • 7.5.4.3. Prevalence Insights
      • 7.5.4.4. Regulatory Framework
      • 7.5.4.5. Reimbursement Structure
      • 7.5.4.6. Argentina Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Middle East & Africa
    • 7.6.1. Middle East & Africa Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.2. South Africa
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Prevalence Insights
      • 7.6.2.4. Regulatory Framework
      • 7.6.2.5. Reimbursement Structure
      • 7.6.2.6. South Africa Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. Saudi Arabia
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Prevalence Insights
      • 7.6.3.4. Regulatory Framework
      • 7.6.3.5. Reimbursement Structure
      • 7.6.3.6. Saudi Arabia Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.4. UAE
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Competitive Scenario
      • 7.6.4.3. Prevalence Insights
      • 7.6.4.4. Regulatory Framework
      • 7.6.4.5. Reimbursement Structure
      • 7.6.4.6. UAE Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.5. Kuwait
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Competitive Scenario
      • 7.6.5.3. Prevalence Insights
      • 7.6.5.4. Regulatory Framework
      • 7.6.5.5. Reimbursement Structure
      • 7.6.5.6. Kuwait Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company Categorization
  • 8.2. Company Market Share Analysis, 2023
  • 8.3. Strategy Mapping
  • 8.4. Company Profiles/Listing
    • 8.4.1. R-Biopharm AG
      • 8.4.1.1. Overview
      • 8.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Strategic Initiatives
    • 8.4.2. EUROIMMUN Medizinische Labordiagnostika AG
      • 8.4.2.1. Overview
      • 8.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Strategic Initiatives
    • 8.4.3. DASIT Group SPA
      • 8.4.3.1. Overview
      • 8.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.3.3. Product Benchmarking
      • 8.4.3.4. Strategic Initiatives
    • 8.4.4. AESKU.GROUP GmbH
      • 8.4.4.1. Overview
      • 8.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Strategic Initiatives
    • 8.4.5. bioMerieux
      • 8.4.5.1. Overview
      • 8.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Strategic Initiatives
    • 8.4.6. Danaher
      • 8.4.6.1. Overview
      • 8.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.6.3. Product Benchmarking
      • 8.4.6.4. Strategic Initiatives
    • 8.4.7. Thermo Fisher Scientific, Inc
      • 8.4.7.1. Overview
      • 8.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.7.3. Product Benchmarking
      • 8.4.7.4. Strategic Initiatives
    • 8.4.8. Stallergenes Greer
      • 8.4.8.1. Overview
      • 8.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.8.3. Product Benchmarking
      • 8.4.8.4. Strategic Initiatives
    • 8.4.9. Minaris Medical America, Inc.
      • 8.4.9.1. Overview
      • 8.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.9.3. Product Benchmarking
      • 8.4.9.4. Strategic Initiatives
    • 8.4.10. Siemens Healthcare GmbH
      • 8.4.10.1. Overview
      • 8.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.10.3. Product Benchmarking
      • 8.4.10.4. Strategic Initiatives
    • 8.4.11. Omega Diagnostics Group PLC
      • 8.4.11.1. Overview
      • 8.4.11.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.11.3. Product Benchmarking
      • 8.4.11.4. Strategic Initiatives
    • 8.4.12. HYCOR Biomedical
      • 8.4.12.1. Overview
      • 8.4.12.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.12.3. Product Benchmarking
      • 8.4.12.4. Strategic Initiatives
    • 8.4.13. Lincoln Diagnostics, Inc.
      • 8.4.13.1. Overview
      • 8.4.13.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.13.3. Product Benchmarking
      • 8.4.13.4. Strategic Initiatives
    • 8.4.14. Alcon
      • 8.4.14.1. Overview
      • 8.4.14.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.14.3. Product Benchmarking
      • 8.4.14.4. Strategic Initiatives
    • 8.4.15. HOB Biotech Group Corp., Ltd.
      • 8.4.15.1. Overview
      • 8.4.15.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.15.3. Product Benchmarking
      • 8.4.15.4. Strategic Initiatives
    • 8.4.16. AbbVie Inc.
      • 8.4.16.1. Overview
      • 8.4.16.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.16.3. Product Benchmarking
      • 8.4.16.4. Strategic Initiatives
    • 8.4.17. Allergy Therapeutics
      • 8.4.17.1. Overview
      • 8.4.17.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.17.3. Product Benchmarking
      • 8.4.17.4. Strategic Initiatives
    • 8.4.18. Sanofi
      • 8.4.18.1. Overview
      • 8.4.18.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.18.3. Product Benchmarking
      • 8.4.18.4. Strategic Initiatives
    • 8.4.19. Pfizer Inc.
      • 8.4.19.1. Overview
      • 8.4.19.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.19.3. Product Benchmarking
      • 8.4.19.4. Strategic Initiatives
    • 8.4.20. Teva Pharmaceutical Industries Ltd.
      • 8.4.20.1. Overview
      • 8.4.20.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.20.3. Product Benchmarking
      • 8.4.20.4. Strategic Initiatives
    • 8.4.21. Sun Pharmaceutical Industries Ltd.
      • 8.4.21.1. Overview
      • 8.4.21.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.21.3. Product Benchmarking
      • 8.4.21.4. Strategic Initiatives
    • 8.4.22. GSK plc
      • 8.4.22.1. Overview
      • 8.4.22.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.22.3. Product Benchmarking
      • 8.4.22.4. Strategic Initiatives
    • 8.4.23. F. Hoffmann-La Roche Ltd.
      • 8.4.23.1. Overview
      • 8.4.23.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.23.3. Product Benchmarking
      • 8.4.23.4. Strategic Initiatives
    • 8.4.24. Merck & Co., Inc.
      • 8.4.24.1. Overview
      • 8.4.24.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.24.3. Product Benchmarking
      • 8.4.24.4. Strategic Initiatives
    • 8.4.25. Astellas Pharma Inc.
      • 8.4.25.1. Overview
      • 8.4.25.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.25.3. Product Benchmarking
      • 8.4.25.4. Strategic Initiatives